Autonomize AI, a company specializing in AI-powered healthcare solutions, has successfully raised $28 million in its latest funding round. The investment was led by Valtruis, The Cigna Group Ventures, and Tau Ventures, with additional participation from existing investors including Asset Management Ventures, ATX Venture Partners, and Capital Factory. This brings the company’s total funding to $32 million.
The new capital will be used to further develop Autonomize AI’s agentic AI orchestration platform. This platform is designed to reduce the administrative workload for healthcare professionals and enhance the overall patient experience. According to Ganesh Padmanabhan, CEO of Autonomize AI, “The current healthcare system is no longer suited for the way care is delivered today, and too often, patients and clinicians pay the price in delayed treatment, wasted time, and unnecessary friction. Automation alone is not the answer for healthcare, but accountable, human-centered AI augmentation is.”
Since its inception in 2022, Autonomize AI’s technology has generated 100,000 automated care plans. These plans have allowed healthcare providers to focus on higher-value patient interactions. The company also reports that its technology has led to 50 percent faster decisions regarding prior authorizations and claims.
